BackInVivo Therapeutics Holdings Overview

InVivo Therapeutics Holdings Cost of Revenue

Cost of Revenue analysis for NVIV.

Quarterly Cost of Revenue

$72000.00
↓ 34.55% YoY

As of Sep 30, 2023

Annual Cost of Revenue (TTM)

$420000.00
↑ 281.82% YoY

Trailing 12 months ending Sep 30, 2023

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin